CSF1R Inhibitor JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Recurrent Adult Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia Interventions: Drug: FMS Inhibitor JNJ-40346527; Other: Pharmacokinetic Study Sponsor: OHSU Knight Cancer Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials